Brief: Shanghai Kehua Bio-Engineering's Holding Company Signs Agreement With South Korea's Seegene
18/10/2018 10:36
Oct 18 (Reuters) - Shanghai Kehua Bio-Engineering Co Ltd
002022.SZ :
* SAYS ITS HOLDING COMPANY SIGNS COOPERATION FRAMEWORK
AGREEMENT
WITH SOUTH KOREA'S SEEGENE ON BUSINESS DEVELOPMENT
Source text in Chinese: https://bit.ly/2J4jBep
Further company coverage: 002022.SZ
(Reporting by Hong Kong newsroom)
((hongkong.newsroom@thomsonreuters.com; (852) 2843-6441;
Reuters Messaging: chyenyee.lee.reuters.com@reuters.net))
Recent news on Seegene
See all newsBrief: Seegene To Cancel 174 Billion Won Worth Of Own Shares
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier